485 related articles for article (PubMed ID: 872954)
21. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
Kamal I; Hefnawi F; Younis N
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
[TBL] [Abstract][Full Text] [Related]
22. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
23. Oral contraceptives and plasma lipids.
Dhillon MK; Sarkar AK; Gupta AN; Devi PK
J Obstet Gynaecol India; 1972; 22(6):622-6. PubMed ID: 12332899
[TBL] [Abstract][Full Text] [Related]
24. Metabolic effects of contraceptive steroids IV. Liver function tests--short term observations.
Gupta I; Nath R; Chaudhury RR; Devi PK
J Asian Fed Obstet Gynaecol; 1972 Dec; 3(2):112-5. PubMed ID: 12310410
[TBL] [Abstract][Full Text] [Related]
25. Letter: The effect of contraceptive steroids on carbohydrate metabolism.
Davidson MB
Metabolism; 1974 Jul; 23(7):687-90. PubMed ID: 4834911
[TBL] [Abstract][Full Text] [Related]
26. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
Odlind V; Weiner E; Victor A; Johansson ED
Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
28. Some observations on the changes in capillary resistance in oral contraceptive users.
Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
30. Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Worthington M; Proudler AJ; Felton C; Sidhu M; Stevenson JC
Contraception; 1993 Sep; 48(3):217-27. PubMed ID: 8222652
[TBL] [Abstract][Full Text] [Related]
31. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
Hausmann L; Goebel KM; Klähn D; Kaffarnik H
Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
[TBL] [Abstract][Full Text] [Related]
32. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
Basdevant A; Conard J; Pelissier C; Guyene TT; Lapousterle C; Mayer M; Guy-Grand B; Degrelle H
Contraception; 1993 Sep; 48(3):193-204. PubMed ID: 8222650
[TBL] [Abstract][Full Text] [Related]
33. Biochemical effects of treatment with oral contraceptive steroids on the dopaminergic system of the rat.
Algeri S; Ponzio F; Dolfini E; Jori A
Neuroendocrinology; 1976; 22(4):343-51. PubMed ID: 1030500
[TBL] [Abstract][Full Text] [Related]
34. Clinical investigation of the biological effects of a new combination low-dose oral contraceptive ('Ovostat E').
Tarkkila T; Hulkko S; Alapiessa U; Kauraniemi T
Curr Med Res Opin; 1977; 5(3):247-51. PubMed ID: 162661
[TBL] [Abstract][Full Text] [Related]
35. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
36. Effect of ethynodiol diacetate and combination--type oral contraceptive compounds on carbohydrate metabolism. I. Six month intravenous glucose tolerance study.
Goldman JA
Diabetologia; 1975 Feb; 11(1):45-8. PubMed ID: 1140518
[TBL] [Abstract][Full Text] [Related]
37. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
Spellacy WN
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
[TBL] [Abstract][Full Text] [Related]
38. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
[TBL] [Abstract][Full Text] [Related]
39. Malignant hypertension with irreversible renal failure due to oral contraceptives.
Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of the metabolic effects of injectable and oral contraceptives.
Liew DF; Ng CS; Heng SH; Ratnam SS
Contraception; 1986 Apr; 33(4):385-94. PubMed ID: 2942334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
